Aim Bulletin
Cronin teams up with second pioneer for DigitalGlassware development
Digital chemistry firm Cronin Group announced on Wednesday that it has secured a second agreement with an unnamed company as part of its DigitalGlassware pioneer programme.
Only the rain will halt Kodal Minerals' drilling programme at Bougouni
Mineral exploration and development company Kodal Minerals announced on Thursday that it plans to continue drilling on its Malian Bougouni lithium project until the start of the rainy season in June or July.
Angle optimises first ever workflow to culture CTCs
AIM-quoted liquid biopsy company Angle has demonstrated a workflow for culturing circulating tumour cells using its Parsortix system.
OptiBiotix hires new online sales and marketing head
Biotechnology company OptiBiotix Health has appointed Steven Riley as head of its online sales and marketing division.
Thor Mining shares boosted amid imminent Bonya Creek acquisitions
Exploration and development company Thor Mining announced on Thursday that it is clear to proceed with the acquisition of further acreage in Australia’s Northern Territory.
Redcentric trading in line with expectations
AIM-listed Redcentric, an IT managed services provider, said on Thursday that its trading results for the year to the end of March were in line with the board’s expectations.
MyCelx raises revenue forecasts after new orders
Clean water technology company MyCelx Technologies Corporation has secured a new purchase order in Saudi Arabia, and has sold equipment in Australia, it announced on Thursday.
RhythmOne prepares shareholders for bumper results
RhythmOne issued a preliminary update on its expected performance for the full year ended 31 March on Thursday, confirming it was in-line with expectations.
Sunrise Resources posts results from Baker's Gold exploration
Sunrise Resources updated the market on the results of exploration it recently carried out at its Baker's Gold Project in Western Australia on Thursday.
Mpac trading in line as chairman steps down
Packaging company Mpac Group told investors that trading in its first quarter was ahead of last year and in line with the board’s expectations on Thursday, as they gathered for the annual general meeting.
Frontera Resources completes drilling at Dino-2 well
European focused exploration and production company Frontera Resources has successfully completed drilling operations at the Dino-2 well, the second well in a three-well drilling campaign at its Taribani asset in Georgia.
Rose Petroleum's new operational team boosts progress and identifies savings
Natural resources firm Rose Petroleum’s newly assembled operational team are close to completing the first phase of well design work at the company’s 75%-owned project in the Paradox Basin, Utah.
Gattaca shares tank as telecoms business continues to disappoint
Specialist engineering and technology recruitment business Gattaca watched its shares fall through the floor on Thursday, after it announced its interim results for the six months ended 31 January, with diluted earnings per share down 25%.
CEO of hVIVO steps down as profits fall
Clinical development and drug discovery services firm hVIVO announced on Thursday that Kym Denny is stepping down as chief executive, with immediate effect.
Shearwater's new subsidiary GeoLang wins major contract
Digital resilience solutions firm Shearwater Group’s recently-acquired subsidiary GeoLang has won its first major enterprise contract under the G Cloud framework.
Independent Oil & Gas appoints Mark Hughes as COO
Independent Oil & Gas has appointed Mark Hughes as chief operating officer.
Ten Entertainment buys sites in Leeds and Luton, says current trading 'strong'
Tenpin bowling company Ten Entertainment has agreed to buy two further sites in Leeds and Luton from MFA Bowl for £1. 3m in cash, taking its total estate to 44.
ValiRx soars on anti-cancer compound's successful study
Clinical stage biotechnology company ValiRx has seen positive results from recent studies into the effectiveness of its VAL101 compound's ability to induce cancer cells to kill themselves off.
ReNeuron lands £1.5m grant to develop retinal disease treatment
Clinical stage stem cell business ReNeuron Group has won a £1. 5m grant to advance development of its hRPC stem cell therapy candidate for blindness-causing degenerative diseases of the retina.